243590
高铼酸钾
99%
别名:
Potassium oxido(trioxo)rhenium, Potassium tetraoxorhenate(1-)
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
KReO4
化学文摘社编号:
分子量:
289.30
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
233-953-8
MDL number:
Assay:
99%
Form:
powder
InChI key
QFKRWIFGDGKWLM-UHFFFAOYSA-N
InChI
1S/K.4O.Re/q+1;;;;-1;
SMILES string
[K+].[O-][Re](=O)(=O)=O
assay
99%
form
powder
reaction suitability
core: potassium
refractive index
n20/D 1.643 (lit.)
mp
550 °C (lit.)
density
4.887 g/mL at 25 °C (lit.)
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
在环戊二烯基三羰基铼络合物的制备中 KReO4 的还原有望成为合成锝和铼有机金属放射性药物的模型。
存储类别
5.1B - Oxidizing hazardous materials
wgk
WGK 3
ppe
dust mask type N95 (US), Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Spradau, T.W. Katzenellenbogen, J.A.
Organometallics, 17, 2009-2009 (1998)
Julien Le Gal et al.
Journal of inorganic biochemistry, 105(6), 880-886 (2011-04-23)
Assembly of independent chemical modules through oxorhenium coordination by a NS(2)+S chelation motif was applied to the synthesis of RGD (Arg-Gly-Asp) analogs. Modules were assembled through oxorhenium chelation to give a series of 18 metal complexes in good yields and
Yuee Feng et al.
Inorganic chemistry, 48(23), 11058-11066 (2009-11-06)
The detailed syntheses of complexes of the form [Re(O)(X)(RNCH(2)CH(2))(2)N(Me)] (X = Me, Cl, I, R = mesityl, C(6)F(5)), 1-3, incorporating diamidoamine ancillary ligands are described. X-ray crystal structures for the complexes [Re(O)(Me)((C(6)F(5))NCH(2)CH(2))(2)N(Me)], 1a, [Re(O)(I)((C(6)F(5))N CH(2)CH(2))(2)N(Me)], 3a, and [Re(O)(I)((Mes)NCH(2))(2)N(Me)], 3b, are
Supriti Sen et al.
The Analyst, 136(22), 4839-4845 (2011-10-06)
A novel 6-(2-pyridinyl)-5,6-dihydrobenzimidazo[1,2-c]quinazoline (HL) serves as a first-time highly selective and sensitive ratiometric fluorescent chemosensor probe for oxorhenium (ReO(V)) ion in acetonitrile : water = 9 : 1 (v/v) at 25 °C. The decrease in fluorescence at 410 nm and
J Tyler French et al.
Journal of vascular and interventional radiology : JVIR, 21(8), 1271-1279 (2010-05-19)
Minimally invasive interventional cancer therapy with drug-carrying lipid nanoparticles (ie, liposomes) via convection-enhanced delivery by an infusion pump can increase intratumoral drug concentration and retention while facilitating broad distribution throughout solid tumors. The authors investigated the utility of liposome-carrying beta-emitting
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持